Identifiers
Database identifiers and provenance.
- Ligand ID
5CI- PDB
3v8n- UniProt (similar protein)
Q8Y8D7- Target protein
- PA3088
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 519.3
- LogP ≤ 5 -2.41
- H-bond donors ≤ 5 7
- H-bond acceptors ≤ 10 12
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 243.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1nc(c2c(n1)n(c(n2)Br)[C@H]3[C@@H]([C@@H]([C@H](O3)CNC(=O)C(CC(=O)O)(CC(=O)O)O)O)O)Nc1nc(c2c(n1)n(c(n2)Br)[C@H]3[C@@H]([C@@H]([C@H](O3)CNC(=O)C(CC(=O)O)(CC(=O)O)O)O)O)N
InChI=1S/C16H19BrN6O9/c17-15-22-8-11(18)20-4-21-12(8)23(15)13-10(29)9(28)5(32-13)3-19-14(30)16(31,1-6(24)25)2-7(26)27/h4-5,9-10,13,28-29,31H,1-3H2,(H,19,30)(H,24,25)(H,26,27)(H2,18,20,21)/t5-,9-,10-,13-/m1/s1InChI=1S/C16H19BrN6O9/c17-15-22-8-11(18)20-4-21-12(8)23(15)13-10(29)9(28)5(32-13)3-19-14(30)16(31,1-6(24)25)2-7(26)27/h4-5,9-10,13,28-29,31H,1-3H2,(H,19,30)(H,24,25)(H,26,27)(H2,18,20,21)/t5-,9-,10-,13-/m1/s1
QQTQAKWRRPPHOE-MSTPSEHLSA-NQQTQAKWRRPPHOE-MSTPSEHLSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01513
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 5CI →
- PDB RCSB structure 3v8n →
- UniProt UniProt Q8Y8D7 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “5CI”) →
Other binders for this protein
Quick navigation to other ligands bound to PA3088.
PDB 51
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 3
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).